journal article·2025-08Open access

De Novo Design of Efficient NIR‐II‐Activated Heavy‐Atom‐Free Type‐I Photosensitizer for Anti‐Tumor Photoimmunotherapy

Huan Chen, Yu Wang, Zhangxin He, Yingpeng Wan, Chen Cao, Ziwei Lu, Yijian Gao, Xiao Cui, Ka‐Wai Lee, Ji‐Hua Tan, Wenchang Xu, Yuliang Yang, Xiliang Li, Yali Wang, Jianquan Hou, Shengliang Li, Chun‐Sing Lee

Advanced Materials· Volume 37· Issue 33

Abstract

Abstract Type‐I photosensitizers (PSs) are considered to be efficient agents for overcoming the oxygen‐dependent deficiency of traditional photodynamic therapy (PDT). However, it is still challenging to design type‐I PSs that can be activated by the second near‐infrared (NIR‐II) irradiation. Herein, a series of organic heavy‐atom‐free molecules are designed (named as CTU1, CTU2, and CTU3) and exhibit strong absorption bands over the first near‐infrared and NIR‐II regions. Among them, water‐dispersible CTU3 nanoparticles (NPs) show strong J‐aggregate characteristics and a good NIR‐II absorption band, resulting in highly efficient •O2− generation upon irradiation of 1064 nm light. In addition, the CTU3 NPs also exhibit a high photothermal conversion efficiency of 88.6%. In vitro and in vivo experiments show that CTU3 NPs have superior PDT and photothermal therapy (PTT) effects, which can further induce immunogenic cell death and activate immune cells in 4T1 tumor‐bearing mice for combined PDT/PTT anti‐tumor photoimmunotherapy against refractory tumors. This work presents a paradigm of de novo design of NIR‐II light‐activated type‐I PS for combinational photoimmunotherapy of cancer.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center of Super‐Diamond and Advanced Films (COSDAF) Department of Chemistry City University of Hong Kong Hong Kong 000000 P. R. China

College of Pharmaceutical Sciences Soochow University Suzhou 215123 P. R. China

The Fourth Affiliated Hospital of Soochow University Medical Center of Soochow University Suzhou Dushu Lake Hospital Suzhou 215000 P. R. China

Department of Radiology The First Affiliated Hospital of Soochow University Suzhou 215006 P. R. China

Shenzhen BGI Huo‐Yan Engineering Technology Co., Ltd Shenzhen 518083 P. R. China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Jiangsu Province · University Grants Committee

References (57)

Show source-provided references
1. 10.1002/anie.20180513810.1002/anie.201805138 ↗
2. 10.1038/nrc107010.1038/nrc1070 ↗
3. 10.1038/s41571-020-0410-210.1038/s41571-020-0410-2 ↗
4. 10.1038/s41557-019-0328-410.1038/s41557-019-0328-4 ↗
5. 10.1038/s41467-022-29572-210.1038/s41467-022-29572-2 ↗
6. 10.1021/acs.accounts.0c0060610.1021/acs.accounts.0c00606 ↗
7. 10.1039/D1CS00647A10.1039/D1CS00647A ↗
8. 10.1021/jacs.6b0539010.1021/jacs.6b05390 ↗
9. 10.1021/jacs.4c0192910.1021/jacs.4c01929 ↗
10. 10.1002/adhm.20190013210.1002/adhm.201900132 ↗
11. 10.1021/acs.chemrev.1c0038110.1021/acs.chemrev.1c00381 ↗
12. 10.1039/D0CS01370F10.1039/D0CS01370F ↗
13. 10.1002/anie.20190734310.1002/anie.201907343 ↗
14. Pang E. · Acc. Chem. Res. · 2022 · 472
15. 10.1021/jacs.3c0164510.1021/jacs.3c01645 ↗
16. 10.1002/anie.20201639910.1002/anie.202016399 ↗
17. 10.1002/agt2.7000710.1002/agt2.70007 ↗
18. 10.1038/s41467-023-37156-x10.1038/s41467-023-37156-x ↗
19. 10.1038/s44222-024-00196-z10.1038/s44222-024-00196-z ↗
20. 10.1021/acs.accounts.2c0053110.1021/acs.accounts.2c00531 ↗
21. 10.1002/anie.20210674810.1002/anie.202106748 ↗
22. 10.1038/s41467-022-33924-310.1038/s41467-022-33924-3 ↗
23. 10.1038/s41467-023-43890-z10.1038/s41467-023-43890-z ↗
24. 10.1038/s41467-024-49311-z10.1038/s41467-024-49311-z ↗
25. 10.1038/s41467-024-46768-w10.1038/s41467-024-46768-w ↗
26. 10.1021/acsnano.2c1231910.1021/acsnano.2c12319 ↗
27. 10.1039/b810313e10.1039/b810313e ↗
28. 10.1021/jacs.1c0737910.1021/jacs.1c07379 ↗
29. 10.1038/s41467-018-04318-110.1038/s41467-018-04318-1 ↗
30. 10.1038/s41467-020-15095-110.1038/s41467-020-15095-1 ↗
31. 10.1038/nmat447610.1038/nmat4476 ↗
32. 10.1021/jacs.9b1004310.1021/jacs.9b10043 ↗
33. 10.1002/adma.20230484810.1002/adma.202304848 ↗
34. 10.1002/anie.20240730710.1002/anie.202407307 ↗
35. 10.1002/adma.20230190110.1002/adma.202301901 ↗
36. 10.1002/anie.20250371810.1002/anie.202503718 ↗
37. 10.1038/s41467-023-37586-710.1038/s41467-023-37586-7 ↗
38. 10.1002/adfm.20241020210.1002/adfm.202410202 ↗
39. 10.1002/adma.20230974810.1002/adma.202309748 ↗
40. 10.1002/adma.20210814610.1002/adma.202108146 ↗
41. 10.1002/smll.20210039810.1002/smll.202100398 ↗
42. 10.1002/adfm.20242316510.1002/adfm.202423165 ↗
43. 10.1016/j.isci.2021.10226110.1016/j.isci.2021.102261 ↗
44. 10.1002/adma.20190785510.1002/adma.201907855 ↗
45. 10.1021/jacs.2c1186810.1021/jacs.2c11868 ↗
46. 10.1038/s41467-021-22686-z10.1038/s41467-021-22686-z ↗
47. 10.1126/sciadv.add566010.1126/sciadv.add5660 ↗
48. 10.1021/jacs.4c0947010.1021/jacs.4c09470 ↗
49. 10.1002/adhm.20210160710.1002/adhm.202101607 ↗
50. 10.1002/anie.20240887410.1002/anie.202408874 ↗
51. 10.1039/C5SC01733E10.1039/C5SC01733E ↗
52. 10.1038/s41467-019-13202-510.1038/s41467-019-13202-5 ↗
53. 10.1002/adfm.20240648310.1002/adfm.202406483 ↗
54. 10.1021/jacs.3c1322410.1021/jacs.3c13224 ↗
55. 10.1021/jacs.3c0818110.1021/jacs.3c08181 ↗
56. 10.1002/anie.20240639210.1002/anie.202406392 ↗
57. 10.1021/jacs.4c1302210.1021/jacs.4c13022 ↗